腹主动脉瘤修复术后急性肾损伤预防策略的系统综述与荟萃分析
该系统综述与荟萃分析纳入17项随机对照试验共1443例择期腹主动脉瘤修复患者,评估多种预防干预对术后急性肾损伤(AKI)的影响。结果显示甘露醇、抗氧化补充剂复合物、开放腹膜外入路和人房钠尿肽可能具有保护作用,而姜黄素、甲泼尼龙、二氧化碳造影剂、血流动力学监测和N-乙酰半胱氨酸无效。远程缺血预适应(RIPC)与标准治疗无统计学显著差异(OR 1.20,95%CI 0.37-3.89),但异质性较大(I2=70%)。
要点
- 甘露醇、抗氧化补充剂复合物、开放腹膜外入路和人房钠尿肽可能减少腹主动脉瘤修复术后AKI。
- 姜黄素、甲泼尼龙、二氧化碳造影剂、血流动力学监测和N-乙酰半胱氨酸未显示有效。
- 远程缺血预适应与标准治疗无显著差异,且异质性高,需谨慎解读。
核心结论
- 甘露醇、抗氧化补充剂复合物、开放腹膜外入路和人房钠尿肽在减少腹主动脉瘤修复术后AKI方面显示一定潜力。
- 上述结论受纳入试验样本量小、偏倚风险高和不一致性限制。
研究设计与样本
- 系统综述与荟萃分析,纳入17项随机对照试验,共1443例择期腹主动脉瘤修复患者。
- 纳入试验为10例及以上患者,比较预防干预与标准治疗或安慰剂,排除混合人群如主动脉闭塞性疾病、胸腹主动脉瘤或破裂动脉瘤。
- 检索Medline(1966-2019)、EMBASE(1947-2019)、CINAHL(1961-2019)、Web of Science(1945-2019)、Scopus(1966-2019)和Cochrane Library(1996-2019)的英文发表试验。
- 使用Cochrane协作网偏倚风险评估工具评价研究质量,采用随机效应荟萃分析合并相似干预结果。
主要发现
- 多数试验为小型单中心研究,AKI定义不一,偏倚风险高或中等。
- 远程缺血预适应(RIPC)的荟萃分析纳入6项试验共355例参与者,RIPC与标准治疗无统计学显著差异(OR 1.20,95%CI 0.37-3.89),异质性较大(I2=70%)。
- 所研究的干预均未显著减少肾脏替代治疗(RRT)的使用。
关键数值与推荐
- RIPC与标准治疗比较:OR 1.20,95%CI 0.37-3.89,异质性I2=70%。
- 可能具有保护作用的干预:甘露醇、抗氧化补充剂复合物、开放腹膜外入路、人房钠尿肽。
- 无效的干预:姜黄素、甲泼尼龙、二氧化碳造影剂、血流动力学监测、N-乙酰半胱氨酸。
临床怎么用
- 当前证据不足以推荐常规使用任何单一干预预防腹主动脉瘤修复术后AKI。
- 甘露醇、抗氧化补充剂复合物、开放腹膜外入路和人房钠尿肽可考虑个体化应用,但需权衡证据不确定性。
- RIPC不推荐作为常规预防措施,因无显著获益且异质性高。
局限性
- 纳入试验多数样本量小、为单中心研究。
- AKI定义不一致。
- 偏倚风险高或中等。
- 试验间存在不一致性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGOUND: To assess the effect of various preventative interventions for reducing the incidence of postoperative acute kidney injury (AKI) in patients undergoing elective abdominal aortic aneurysm (AAA) repair. METHODS: We included randomized controlled trials of 10 patients or more which tested a preventative intervention versus standard therapy or placebo in patients undergoing elective AAA repair using the open or endovascular approach. Studies including mixed patient populations such as those with aortic occlusive disease, thoracoabdominal aneurysms or ruptured aneurysms were ineligible for review. We searched Medline (1966-2019), EMBASE (1947-2019), CINAHL (1961-2019), Web of Science (1945-2019), Scopus (1966-2019), and The Cochrane Library (1996-2019) for trials available as published manuscripts in English. Study quality was assessed using the Cochrane Collaboration risk of bias tool. Where possible we pooled the results of similar interventions using random effects meta-analysis. RESULTS: We included 17 trials involving 1443 participants. Most trials were small, single-center studies, with varying definitions of AKI and a high or moderate risk of bias. The preventative strategies with possible protective effects were mannitol, a composite of antioxidant supplements, an open extraperitoneal approach, and human atrial natriuretic peptide (hANP). Curcumin, methylprednisolone, carbon dioxide contrast medium, hemodynamic monitoring and N-acetylcysteine were found to be ineffective. Six trials with a total of 355 participants reported on remote ischemic preconditioning (RIPC) and our meta-analysis showed no statistically significant difference between RIPC and standard treatment (OR 1.20, 95% CI 0.37, 3.89); although the results should be interpreted with caution due to considerable statistical heterogeneity (I2 = 70%). None of the interventions studied significantly reduced receipt of renal replacement therapy (RRT). CONCLUSIONS: Interventions that have shown some potential to reduce AKI after AAA repair include mannitol, a composite of antioxidant supplements, an open extraperitoneal approach and hANP. These conclusions are limited by the small size, high risk of bias and inconsistency of the included trials. Large, high quality, multi-center randomized trials will help determine which interventions are effective in reducing the incidence of postoperative AKI among patients undergoing elective AAA repair.
引用
- Fernandes M, Majoni M, Garg AX, et al. Systematic Review and Meta-Analysis of Preventative Strategies for Acute Kidney Injury in Patients Undergoing Abdominal Aortic Aneurysm Repair. Ann Vasc Surg. 2021. PMID: 33548402. doi:10.1016/j.avsg.2020.12.061
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。